Oligodendrocytes in Huntington's Disease: A Review of Oligodendrocyte Pathology and Current Cell Reprogramming Approaches for Oligodendrocyte Modelling of Huntington's Disease
Journal of Neuroscience Research · 2024
DOI: 10.1002/jnr.70010 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Neuroscience Research, 2024. Verfasst von Amelie Marie Back und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Clinical Pharmacology, Faculty of Medical and Health Sciences, School of Medical Science, Centre for Brain Research, U…. Hauptthemen laut MEDLINE: Huntington Disease, Oligodendroglia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 129 Literaturangaben. Gefördert von: Maurice & Phyllis Paykel Trust.
Abstract (Originalsprache)
Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder traditionally characterized by the selective loss of medium spiny neurons in the basal ganglia. However, it has become apparent that white matter injury and oligodendrocyte dysfunction precede the degeneration of medium spiny neurons, garnering interest as a key pathogenic mechanism of HD. Oligodendrocytes are glial cells found within the central nervous system involved in the production of myelin and the myelination of axons. Myelin is a lipid‐rich sheath that wraps around axons, facilitating signal conduction and neuronal viability. The degeneration of myelin hinders effective communication and leaves neurons vulnerable to external damage and subsequent degeneration. Abnormalities in oligodendrocyte maturation have been established in the HD human brain, however, investigations into the underlying dysfunction of human oligodendrocytes in HD are limited. This review will detail the involvement of oligodendrocytes and white matter damage in HD. Recent developments in modeling human‐specific oligodendrocyte pathology in HD will be discussed, with a particular focus on emerging somatic cell reprogramming approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology and Clinical Pharmacology, Faculty of Medical and Health Sciences, School of Medical Science, Centre for Brain Research, University of Auckland, Auckland, New Zealand.
ORCID-Profile: Amy McCaughey-Chapman
Förderung
- Maurice & Phyllis Paykel Trust
Zitieren
APA
Back, A. M., Connor, B., & McCaughey-Chapman, A. (2024). Oligodendrocytes in Huntington's Disease: A Review of Oligodendrocyte Pathology and Current Cell Reprogramming Approaches for Oligodendrocyte Modelling of Huntington's Disease. Journal of Neuroscience Research. https://doi.org/10.1002/jnr.70010
Vancouver
Back AM, Connor B, McCaughey-Chapman A. Oligodendrocytes in Huntington's Disease: A Review of Oligodendrocyte Pathology and Current Cell Reprogramming Approaches for Oligodendrocyte Modelling of Huntington's Disease. Journal of Neuroscience Research. 2024. doi:10.1002/jnr.70010
BibTeX
@article{Back2024,
author = {Back, Amelie Marie and Connor, Bronwen and McCaughey-Chapman, Amy},
title = {Oligodendrocytes in Huntington's Disease: A Review of Oligodendrocyte Pathology and Current Cell Reprogramming Approaches for Oligodendrocyte Modelling of Huntington's Disease},
journal = {Journal of Neuroscience Research},
year = {2024},
doi = {10.1002/jnr.70010}
}
EUVIMED